In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. 1997

T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
Osaka University, Suita-city, Japan.

OBJECTIVE To establish a system for efficient, direct in vivo gene transfer into joints. METHODS A hemagglutinating virus of Japan (HVJ; Sendai virus)-liposome suspension containing SV40 large T antigen (SVT) gene was injected intraarticularly into knee joints of 6-week-old female Lewis rats. Rats were killed at various times for immunohistochemical analysis of the expression of SVT gene. RESULTS The expression of SVT gene was detected immunohistochemically in chondrocytes in the superficial and middle zones of articular cartilage in the knee joints. The average percentage of SVT-positive cells was estimated to be approximately 30% on days 3, 7, 14, and 21 after transfection. Moreover, no pathologic change caused by HVJ-liposome injection was observed in the joints. CONCLUSIONS The transfection frequency and stability of expression recognized in this study indicate the possibility of a strategy for treatment of joint disorders, including arthritis, using direct gene transfer.

UI MeSH Term Description Entries
D007270 Injections, Intra-Articular Methods of delivering drugs into a joint space. Intra Articular Injection,Intraarticular Injection,Injections, Intraarticular,Intra-Articular Injections,Intraarticular Injections,Articular Injection, Intra,Articular Injections, Intra,Injection, Intra Articular,Injection, Intra-Articular,Injection, Intraarticular,Injections, Intra Articular,Intra Articular Injections,Intra-Articular Injection
D007592 Joint Diseases Diseases involving the JOINTS. Arthropathies,Arthropathy,Joint Disease
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D002358 Cartilage, Articular A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact. Articular Cartilage,Articular Cartilages,Cartilages, Articular
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000952 Antigens, Polyomavirus Transforming Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle. Polyomavirus Large T Antigens,Polyomavirus Middle T Antigens,Polyomavirus Small T Antigens,Polyomavirus T Proteins,Polyomavirus Transforming Antigens,Polyomavirus Tumor Antigens,SV40 T Antigens,SV40 T Proteins,Simian Sarcoma Virus Proteins,Polyomaviruses Large T Proteins,Polyomaviruses Middle T Proteins,Polyomaviruses Small T Proteins,Antigens, Polyomavirus Tumor,Antigens, SV40 T,Proteins, Polyomavirus T,Proteins, SV40 T,T Antigens, SV40,T Proteins, Polyomavirus,T Proteins, SV40,Transforming Antigens, Polyomavirus,Tumor Antigens, Polyomavirus
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
January 1994, Cancer detection and prevention,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
May 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
July 1997, Molecular and cellular biochemistry,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
December 2005, Transplantation,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
December 1998, Journal of hepatology,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
June 1998, International journal of oncology,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
July 1997, Gene therapy,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
June 2002, Journal of drug targeting,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
August 1985, Experimental cell research,
T Tomita, and H Hashimoto, and N Tomita, and R Morishita, and S B Lee, and K Hayashida, and N Nakamura, and K Yonenobu, and Y Kaneda, and T Ochi
November 1997, Human gene therapy,
Copied contents to your clipboard!